Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegbelfermin in NASH
NCT03400163Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of pegbelfermin in Nonalcoholic steatohepatitis (NASH), sponsored by Bristol Myers Squibb. Started May 2015; status: completed.
02
Drugs
pegbelfermin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03400163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400163.